<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>-6-phosphate dehydrogenase (G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) deficiency is a common condition with a worldwide distribution that has the potential for causing severe <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> with <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0010163'>Hemolysis</z:mp> resulting from identifiable triggers may be the cause of the <z:hpo ids='HP_0000952'>jaundice</z:hpo> in some cases, but in many, <z:hpo ids='HP_0000952'>jaundice</z:hpo> continues to occur despite avoidance of contact with known hemolytic triggers </plain></SENT>
<SENT sid="2" pm="."><plain>In some G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient population groups, carboxyhemoglobin studies have indicated exaggerated <z:mp ids='MP_0010163'>hemolysis</z:mp>; but in others, <z:hpo ids='HP_0001878'>increased hemolysis</z:hpo> has not correlated with serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> values </plain></SENT>
<SENT sid="3" pm="."><plain>As <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> results from an imbalance between <z:chebi fb="0" ids="16990">bilirubin</z:chebi> production and <z:chebi fb="0" ids="16990">bilirubin</z:chebi> elimination, diminished <z:chebi fb="0" ids="16990">bilirubin</z:chebi> conjugation was suspected to contribute to the pathogenesis of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Serum-conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> fractions, reflecting intrahepatocytic <z:chebi fb="0" ids="16990">bilirubin</z:chebi> conjugation, were low in G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates who developed <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>This conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> profile was similar to that seen in adults with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e>, a condition associated with promoter polymorphism for the gene encoding the <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-conjugating enzyme, UGT glucuronosyltransferase 1A1 (UGT) </plain></SENT>
<SENT sid="6" pm="."><plain>Whereas <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G-6-PD deficiency</z:e> or <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e>, alone, did not predispose to <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates who also were heterozygotes or homozygotes for the variant UGT gene promoter did have significantly increased incidences of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Additional conditions which predispose to <z:hpo ids='HP_0006579'>neonatal jaundice</z:hpo> in the presence of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e>, include Coombs' negative ABO blood group heterospecificity, hereditary <z:hpo ids='HP_0004444'>spherocytosis</z:hpo>, and prolonged breastfeeding.<z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e> and <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G-6-PD deficiency</z:e> are both common, inherited conditions </plain></SENT>
<SENT sid="8" pm="."><plain>Individually, and in the absence of additional genetic or environmental factors, both are benign, and should result in minimal health disturbance or interference with the quality of life of affected individuals </plain></SENT>
<SENT sid="9" pm="."><plain>However, in combination, or following exposure to environmental or other genetic factors, these benign conditions may have severe manifestations, with potentially dangerous and possibly life-threatening consequences </plain></SENT>
<SENT sid="10" pm="."><plain>This review highlights the major clinical features of both <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's Syndrome</z:e> and <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G-6-PD deficiency</z:e>, and surveys a series of studies related to <z:hpo ids='HP_0006579'>neonatal jaundice</z:hpo> in G-6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-deficient neonates culminating in the documentation of an interaction between the two conditions that is crucial to the pathogenesis of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
</text></document>